{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T05:40:06Z","timestamp":1792647606738,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP23K17226"],"award-info":[{"award-number":["JP23K17226"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Japan Society for the Promotion of Science","award":["JP22H02793"],"award-info":[{"award-number":["JP22H02793"]}]},{"name":"BRAIN","award":["JPJ009237"],"award-info":[{"award-number":["JPJ009237"]}]},{"name":"Japan Agency for Medical Research and Development","award":["JP26ak0101296"],"award-info":[{"award-number":["JP26ak0101296"]}]},{"name":"Japan Agency for Medical Research and Development","award":["JP25jf0126014"],"award-info":[{"award-number":["JP25jf0126014"]}]},{"name":"Japan Agency for Medical Research and Development","award":["JP24zf0127012"],"award-info":[{"award-number":["JP24zf0127012"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gastric Cancer"],"DOI":"10.1007\/s10120-026-01807-x","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T05:28:28Z","timestamp":1792646908000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lipidomic profiling of peritoneal lavage supernatant identifies PE\/PA\/PI-enriched recurrence biomarkers in cytology-negative gastric cancer"],"prefix":"10.1007","author":[{"given":"Lili","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohito","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Omagari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoshiro","family":"Hirayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoma","family":"Haneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Soneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisuke","family":"Booka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotoshi","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiramatsu","family":"Yohshiriro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Kahyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuma","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroya","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1302-6467","authenticated-orcid":false,"given":"Mitsutoshi","family":"Setou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,22]]},"reference":[{"key":"1807_CR1","doi-asserted-by":"publisher","unstructured":"Li Y, Jiang L, Chen Y, Li Y, Yuan J, Lu J, et al. Specific lineage transition of tumor \u2013 associated macrophages elicits immune evasion of ascitic tumor cells in gastric cancer with peritoneal metastasis. Gastric Cancer [Internet] Springer Nat Singap. 2024;27:519\u201338. https:\/\/doi.org\/10.1007\/s10120-024-01486-6.","DOI":"10.1007\/s10120-024-01486-6"},{"key":"1807_CR2","doi-asserted-by":"publisher","unstructured":"Park JY, Georges D, Alberts CJ, Bray F, Clifford G, Baussano I, et al Global lifetime estimates of expected and preventable gastric cancers across 185 countries. Nat Med. 2025;31(9):3020\u20137. https:\/\/doi.org\/10.1038\/s41591-025-03793-6.","DOI":"10.1038\/s41591-025-03793-6"},{"key":"1807_CR3","doi-asserted-by":"publisher","unstructured":"Thomassen I, Gestel YR, Van RB, Van, Luyer MD, Bosscha K, Nienhuijs SW, et al. Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors. Int J Cancer. 2014;134:622\u20138. https:\/\/doi.org\/10.1002\/ijc.28373.","DOI":"10.1002\/ijc.28373"},{"key":"1807_CR4","doi-asserted-by":"publisher","unstructured":"Sun F, Feng MIN, Guan W. Mechanisms of peritoneal dissemination in gastric cancer (Review). Oncol Lett. 2017;14:6991\u20138. https:\/\/doi.org\/10.3892\/ol.2017.7149.","DOI":"10.3892\/ol.2017.7149"},{"issue":"21","key":"1807_CR5","doi-asserted-by":"publisher","first-page":"4882","DOI":"10.3390\/jcm10214882","volume":"10","author":"A van Rijken","year":"2021","unstructured":"Rijken A, Lurvink RJ, Luyer MD, Nieuwenhuijzen GA, van Erning FN, van Sandick JW, de Hingh IH. The burden of peritoneal metastases from gastric cancer: a systematic review on the incidence, risk factors and survival. J Clin Med. 2021;10(21):4882.","journal-title":"J Clin Med"},{"key":"1807_CR6","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/(SICI)1096-9098(199910)72:2<60::AID-JSO3>3.0.CO;2-1","volume":"72","author":"Y Kodera","year":"1999","unstructured":"Kodera Y, Yamamura Y, Shimizu Y, Torii A, Hirai T, Yasui K, et al. Peritoneal Washing Cytology: Prognostic Value of Positive Findings in Patients with Gastric Carcinoma Undergoing a Potentially. J Surg Oncol. 1999;72:60\u20135.","journal-title":"J Surg Oncol"},{"key":"1807_CR7","doi-asserted-by":"publisher","unstructured":"Cie\u00b4sla S, Lisiecki R, \u0141awnicka A, Kudli\u00b4nski B, Ostrowska P, Dav\u00ec A, et al. Clinical significance of peritoneal fluid examination for free cancer cells in patients qualified for surgery for gastric cancer. Front Surg. 2021;8:1\u20139. https:\/\/doi.org\/10.3389\/fsurg.2021.685868.","DOI":"10.3389\/fsurg.2021.685868"},{"key":"1807_CR8","doi-asserted-by":"publisher","unstructured":"Fu M, Lin Y, Yang J, Cheng J, Lin L, Wang G, et al. Multitask machine learning \u2013 based tumor \u2013 associated collagen signatures predict peritoneal recurrence and disease \u2013 free survival in gastric cancer. Gastric Cancer [Internet] Springer Nat Singap. 2024;27:1242\u201357. https:\/\/doi.org\/10.1007\/s10120-024-01551-0.","DOI":"10.1007\/s10120-024-01551-0"},{"key":"1807_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.5230\/jgc.2014.14.1.23","volume":"14","author":"K Kang","year":"2014","unstructured":"Kang K, Hur H, Byun CS, Kim YB, Han S, Cho YK. Conventional cytology is not beneficial for predicting peritoneal recurrence after curative surgery for gastric cancer: results of a prospective clinical study. J Gastric Cancer. 2014;14:23\u201331.","journal-title":"J Gastric Cancer"},{"key":"1807_CR10","doi-asserted-by":"publisher","unstructured":"Matsuoka T, Yashiro M. Significance of peritoneal lavage cytology based on genetic signatures in gastric cancer. J Cancer Metastasis Treat. 2018. https:\/\/doi.org\/10.20517\/2394-4722.2017.85. 4.","DOI":"10.20517\/2394-4722.2017.85"},{"key":"1807_CR11","doi-asserted-by":"publisher","unstructured":"Pan M, Qin C, Han X. Lipid metabolism and lipidomics applications in cancer research. Adv Exp Med Biol. 2021;1316:1\u201324. https:\/\/doi.org\/10.1007\/978-981-33-6785-2.","DOI":"10.1007\/978-981-33-6785-2"},{"issue":"1","key":"1807_CR12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13104-026-07633-9","volume":"19","author":"Y Takanashi","year":"2026","unstructured":"Takanashi Y, Kitamoto T, Kondo M, Takei K, Shibata M, Sekihara K, Funai K. Lipidomic signatures in lung adenocarcinoma and spontaneous pneumothorax tissues associated with heated tobacco use: a pilot study. BMC Res Notes. 2026;19(1):87.","journal-title":"BMC Res Notes"},{"key":"1807_CR13","doi-asserted-by":"publisher","unstructured":"Aramaki S, Tsuge S, Islam A, Eto F, Sakamoto T, Oyama S, et al. Lipidomics-based tissue heterogeneity in specimens of luminal breast cancer revealed by clustering analysis of mass spectrometry imaging: A preliminary study. PLoS One [Internet]. 2023;18:1\u201314. https:\/\/doi.org\/10.1371\/journal.pone.0283155.","DOI":"10.1371\/journal.pone.0283155"},{"key":"1807_CR14","doi-asserted-by":"publisher","unstructured":"Afroz MS, Aramaki S, Rahman MM, Dubail M, Chi Z, Fujii K, Hanaka H. LC-MS\/MS and high-spatial single-cell MSI reveal selective downregulation of PC (16: 0_16: 0) and PC (18: 0_18: 1) due to mPGES-1 knockdown in hormone-resistant prostate cancer cell line. Anal Bioanal Chem. 2026;16(20):6705\u201319 https:\/\/doi.org\/10.1007\/s00216-025-06296-y","DOI":"10.1007\/s00216-025-06296-y"},{"key":"1807_CR15","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1245\/s10434-015-4459-6","volume":"23","author":"T Uehara","year":"2016","unstructured":"Uehara T, Hirotoshi K, Shinichiro M, Ichirota I, Tomohiko S, Yoshihiro H, et al. Overexpression of lysophosphatidylcholine acyltransferase 1 and concomitant lipid alterations in gastric cancer. Ann Surg Oncol. 2016;23:206\u201313.","journal-title":"Ann Surg Oncol"},{"key":"1807_CR16","doi-asserted-by":"publisher","unstructured":"Saito R, Yoshimura K, Shoda K, Furuya S. Diagnostic significance of plasma lipid markers and machine learning\u2013based algorithm for gastric cancer. Oncol Lett. 2021;21:1\u20138. https:\/\/doi.org\/10.3892\/ol.2021.12666.","DOI":"10.3892\/ol.2021.12666"},{"issue":"8","key":"1807_CR17","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1021\/jasms.4c00505","volume":"36","author":"Y Shi","year":"2025","unstructured":"Shi Y, Yang Q, Xu B, Yuan C, Qi K, Pan Y, Chai J. Key lipid reprogramming revealed in gastric signet ring cell carcinoma by spatial mass spectrometry metabolomics. J Am Soc Mass Spectrom. 2025;36(8):1598\u2013608.","journal-title":"J Am Soc Mass Spectrom"},{"key":"1807_CR18","doi-asserted-by":"publisher","unstructured":"Morita Y, Ikegami K, Goto-inoue N, Hayasaka T, Zaima N, Tanaka H, et al. Imaging mass spectrometry of gastric carcinoma in formalin-fixed paraffin-embedded tissue microarray. Cancer Sci. 2010;101:267\u201373. https:\/\/doi.org\/10.1111\/j.1349-7006.2009.01384.x.","DOI":"10.1111\/j.1349-7006.2009.01384.x"},{"key":"1807_CR19","doi-asserted-by":"publisher","unstructured":"Wang W, Zhen S, Ping Y. Metabolomic biomarkers in liquid biopsy: accurate cancer diagnosis and prognosis monitoring. Front Oncol. 2024;14:1\u201320. https:\/\/doi.org\/10.3389\/fonc.2024.1331215.","DOI":"10.3389\/fonc.2024.1331215"},{"key":"1807_CR20","doi-asserted-by":"publisher","unstructured":"Kaji S, Irino T, Kusuhara M, Makuuchi R, Yamakawa Y, Tokunaga M. Metabolomic profiling of gastric cancer tissues identified potential biomarkers for predicting peritoneal recurrence. Gastric Cancer [Internet] Springer Singap. 2020;23:874\u201383. https:\/\/doi.org\/10.1007\/s10120-020-01065-5.","DOI":"10.1007\/s10120-020-01065-5"},{"issue":"4","key":"1807_CR21","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3390\/metabo15040222","volume":"15","author":"L Zhou","year":"2025","unstructured":"Zhou L, Su B, Shan Z, Gao Z, Guo X, Wang W, Lin X. Metabolic Reprogramming of gastric cancer revealed by a liquid chromatography\u2013mass spectrometry-based metabolomics study. Metabolites. 2025;15(4):222.","journal-title":"Metabolites"},{"key":"1807_CR22","doi-asserted-by":"publisher","unstructured":"Chen Y, Wang B, Zhao Y, Shao X, Wang M, Ma F, Hu Z Metabolomic machine learning predictor for diagnosis and prognosis of gastric cancer. Nat Commun. 2024;15(1):1657. https:\/\/doi.org\/10.1038\/s41467-024-46043-y.","DOI":"10.1038\/s41467-024-46043-y"},{"key":"1807_CR23","doi-asserted-by":"publisher","unstructured":"Liu Y, Bian B, Chen S, Zhou B, Zhang P, Shen L, et al. Identification and validation of four serum biomarkers with optimal diagnostic and prognostic potential for gastric cancer based on machine learning algorithms. Cancer Med. 2025;14:1\u201313. https:\/\/doi.org\/10.1002\/cam4.70659.","DOI":"10.1002\/cam4.70659"},{"key":"1807_CR24","first-page":"1","volume":"61","author":"C Colak","year":"2025","unstructured":"Colak C, Yagin FH, Algarni A, Algarni A, Al-hashem F, Paolo L. Untargeted Lipidomic Biomarkers for Liver Cancer Diagnosis: A Tree-Based Machine Learning Model Enhanced by Explainable Artificial Intelligence. Med (B Aires). 2025;61:1\u201315.","journal-title":"Med (B Aires)"},{"key":"1807_CR25","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10120-011-0041-5","volume":"14","author":"Japanese Gastric Cancer Association","year":"2011","unstructured":"Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14:101\u201312.","journal-title":"Gastric Cancer"},{"key":"1807_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10120-016-0622-4","volume":"20","author":"Japanese Gastric Cancer Association","year":"2017","unstructured":"Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2017;20:1\u201319.","journal-title":"Gastric Cancer"},{"key":"1807_CR27","doi-asserted-by":"publisher","first-page":"93","DOI":"10.11477\/mf.1542905045","volume":"40","author":"Y Hirooka","year":"2001","unstructured":"Hirooka Y, Kaihara N. Igan no jutsuchu fukunai senjo saiboshin guideline [Guidelines for intraoperative peritoneal lavage cytology in gastric cancer]. J Japanese Soc Clin Cytol. 2001;40:93\u20138. https:\/\/doi.org\/10.11477\/mf.1542905045.","journal-title":"J Japanese Soc Clin Cytol"},{"key":"1807_CR28","unstructured":"Japanese Society of Clinical Cytology. Saiboshin Guideline 5: Shokaki 2015 [Cytology Guideline 5: Gastrointestinal Tract, 2015 Edition]. Kanehara Shuppan; 2015."},{"key":"1807_CR29","doi-asserted-by":"publisher","unstructured":"Japanese Gastric Cancer Association. Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition). Gastric Cancer. 2023;2021:1\u201325. https:\/\/doi.org\/10.1007\/s10120-022-01331-8.","DOI":"10.1007\/s10120-022-01331-8"},{"key":"1807_CR30","doi-asserted-by":"publisher","unstructured":"Xu T, Hu C, Xuan Q, Xu G. Analytica Chimica Acta Recent advances in analytical strategies for mass spectrometry-based lipidomics. Anal Chim Acta [Internet] Elsevier Ltd. 2020;1137:156\u201369. https:\/\/doi.org\/10.1016\/j.aca.2020.09.060.","DOI":"10.1016\/j.aca.2020.09.060"},{"key":"1807_CR31","doi-asserted-by":"publisher","unstructured":"Sud M, Fahy E, Cotter D, Brown A, Dennis EA, Glass CK, et al. LMSD: LIPID MAPS structure database. Nucleic Acids Res. 2007;35:527\u201332. https:\/\/doi.org\/10.1093\/nar\/gkl838.","DOI":"10.1093\/nar\/gkl838"},{"key":"1807_CR32","doi-asserted-by":"publisher","unstructured":"Wishart DS, Feunang YD, Marcu A, Guo AC, Liang K, Rosa V, et al. HMDB 4. 0 : the human metabolome database for 2018. Nucleic Acids Res. 2018;46:608\u201317. https:\/\/doi.org\/10.1093\/nar\/gkx1089.","DOI":"10.1093\/nar\/gkx1089"},{"key":"1807_CR33","doi-asserted-by":"publisher","unstructured":"Xu, S., Bai, C., Chen, Y., Yu, L., Wu, W., & Hu, K. (2024). Comparing univariate filtration preceding and succeeding PLS-DA analysis on the differential variables\/metabolites identified from untargeted LC-MS metabolomics data. Analytica chimica acta, 1287, 342103. https:\/\/doi.org\/10.1016\/j.aca.2023.342103","DOI":"10.1016\/j.aca.2023.342103"},{"key":"1807_CR34","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1080\/14789450.2020.1880897","volume":"17","author":"M Mamun","year":"2020","unstructured":"Mamun M, Al, Islam A, Eto F, Sato T, Kahyo T, Setou M. Mass spectrometry-based phospholipid imaging: methods and findings. Expert Rev Proteom. 2020;17:843\u201354.","journal-title":"Expert Rev Proteom"},{"issue":"1","key":"1807_CR35","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12944-024-02121-0","volume":"23","author":"Y Takanashi","year":"2024","unstructured":"Takanashi Y, Kahyo T, Sekihara K, Kawase A, Setou M, Funai K. Prognostic potential of lipid profiling in cancer patients: a systematic review of mass spectrometry-based studies. Lipids Health Dis. 2024;23(1):154.","journal-title":"Lipids Health Dis"},{"key":"1807_CR36","doi-asserted-by":"publisher","unstructured":"Nair U, Jotwani A, Geng J, Gammoh N, Richerson D, Yen W, et al. SNARE Proteins Are Required for Macroautophagy. Cell [Internet] Elsevier Inc. 2011;146:290\u2013302. https:\/\/doi.org\/10.1016\/j.cell.2011.06.022.","DOI":"10.1016\/j.cell.2011.06.022"},{"key":"1807_CR37","doi-asserted-by":"publisher","unstructured":"Tan LT, Chan K, Pusparajah P, Lee W, Chuah L, Khan TM, et al. Targeting Membrane Lipid a Potential Cancer Cure? Front Pharmacol. 2017;8:1\u20136. https:\/\/doi.org\/10.3389\/fphar.2017.00012.","DOI":"10.3389\/fphar.2017.00012"},{"key":"1807_CR38","doi-asserted-by":"publisher","first-page":"181","DOI":"10.4251\/wjgo.v11.i3.181","volume":"5204","author":"C-Y Hung","year":"2019","unstructured":"Hung C-Y, Yeh T-S, Tsai C-K, Wu R-C, Lai Y-C, Chiang M-H, et al. Glycerophospholipids pathways and chromosomal instability in gastric cancer: Global lipidomics analysis. World J Gastrointest Oncol. 2019;5204:181\u201394.","journal-title":"World J Gastrointest Oncol"},{"key":"1807_CR39","doi-asserted-by":"publisher","unstructured":"Shao W, Espenshade PJ. Expanding Roles for SREBP in Metabolism. Cell Metab [Internet] Elsevier. 2012;16:414\u20139. https:\/\/doi.org\/10.1016\/j.cmet.2012.09.002.","DOI":"10.1016\/j.cmet.2012.09.002"},{"key":"1807_CR40","first-page":"1","volume":"17","author":"Z Chen","year":"2025","unstructured":"Chen Z, Dong C, Chen L, Song M, Zhou X, Lv D, et al. The Changes in Plasmalogens: Chemical Diversity and Nutritional Implications\u2014A. Narrative Rev Nutrients. 2025;17:1\u201318.","journal-title":"Narrative Rev Nutrients"},{"key":"1807_CR41","first-page":"1","volume":"17","author":"M Cristina","year":"2018","unstructured":"Cristina M, Messias F, Mecatti GC, Priolli DG. Plasmalogen lipids: functional mechanism and their involvement in gastrointestinal cancer. Lipids Health Dis Lipids Health Disease. 2018;17:1\u201312.","journal-title":"Lipids Health Dis Lipids Health Disease"},{"key":"1807_CR42","doi-asserted-by":"publisher","unstructured":"Toschi A, Lee E, Xu L, Garcia A, Gadir N, David A, et al. Regulation of mTORC1 and mTORC2 Complex Assembly by Phosphatidic Acid: Competition with Rapamycin Regulation of mTORC1 and mTORC2 Complex Assembly by Phosphatidic Acid : Competition with Rapamycin. Mol Cell Biol. 2023;29:1411\u201320. https:\/\/doi.org\/10.1128\/MCB.00782-08.","DOI":"10.1128\/MCB.00782-08"},{"key":"1807_CR43","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.bbalip.2009.02.009.Phosphatidic","volume":"1791","author":"DA Foster","year":"2009","unstructured":"Foster DA. Phosphatidic acid signaling to mTOR: Signals for the survival of human cancer cells. Biochim Biophys Acta. 2009;1791:949\u201355. https:\/\/doi.org\/10.1016\/j.bbalip.2009.02.009.Phosphatidic.","journal-title":"Biochim Biophys Acta"},{"key":"1807_CR44","doi-asserted-by":"crossref","unstructured":"Torres-Ayuso P, Daza-Mart\u00edn M, Mart\u00edn-P\u00e9rez J, \u00c1vila-Flores A, M\u00e9rida I. Diacylglycerol kinase \u03b1 promotes 3D cancer cell growth and limits drug sensitivity through functional interaction with Src. Oncotarget. 2014;5(20):9710.","DOI":"10.18632\/oncotarget.2344"},{"key":"1807_CR45","doi-asserted-by":"publisher","unstructured":"Cai K, Mulatz K, Ard R, Nguyen T, Gee SH. Increased diacylglycerol kinase \u03b6 expression in human metastatic colon cancer cells augments Rho GTPase activity and contributes to enhanced invasion. BMC Cancer [Internet] BMC Cancer. 2014;14:1\u201310. https:\/\/doi.org\/10.1186\/1471-2407-14-208.","DOI":"10.1186\/1471-2407-14-208"},{"key":"1807_CR46","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1042\/BST0390495","volume":"39","author":"CA Lewis","year":"2011","unstructured":"Lewis CA, Griffiths B, Santos CR, Pende M, Schulze A. Regulation of the SREBP transcription factors by mTORC1. Biochem Soc Trans. 2011;39:495\u20139.","journal-title":"Biochem Soc Trans"},{"key":"1807_CR47","doi-asserted-by":"publisher","unstructured":"Peterson TR, Sengupta SS, Harris TE, Carmack AE, Kang SA, Balderas E, Sabatini DM. mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway. Cell. 2011;146(3):408\u201320. . https:\/\/doi.org\/10.1016\/j.cell.2011.06.034","DOI":"10.1016\/j.cell.2011.06.034"},{"key":"1807_CR48","doi-asserted-by":"crossref","unstructured":"Alizadeh H, Kerachian S, Jabbari K, Soltani BM. Phosphatidic acid as a cofactor of mTORC1 in platinum-based chemoresistance: Mechanisms and therapeutic potential. Eur J Pharmacol. 2025;988:177220.","DOI":"10.1016\/j.ejphar.2024.177220"},{"key":"1807_CR49","doi-asserted-by":"publisher","unstructured":"He Y, Sun MM, Zhang GG, Yang J, Chen KS, Xu WW, Li B Targeting PI3K\/Akt signal transduction for cancer therapy. Signal Transduct Target therapy. 2021;6(1):425. https:\/\/doi.org\/10.1038\/s41392-021-00828-5.","DOI":"10.1038\/s41392-021-00828-5"},{"key":"1807_CR50","doi-asserted-by":"publisher","unstructured":"Porta C, Paglino C, Mosca A. Targeting PI3K\/Akt\/mTOR signaling in cancer. Front Oncol. 2014;4:1\u201311. https:\/\/doi.org\/10.3389\/fonc.2014.00064.","DOI":"10.3389\/fonc.2014.00064"},{"key":"1807_CR51","doi-asserted-by":"publisher","unstructured":"Wang F, Pang R, Zhao X, Zhou B. Plasma metabolomics and lipidomics reveal potential novel biomarkers in early gastric cancer: An explorative study. Int J Biol Markers. 2024;39:226\u201338. https:\/\/doi.org\/10.1177\/03936155241258780.","DOI":"10.1177\/03936155241258780"},{"key":"1807_CR52","doi-asserted-by":"publisher","first-page":"7199","DOI":"10.2147\/OTT.S245663","volume":"13","author":"G Pan","year":"2020","unstructured":"Pan G, Ma Y, Suo J, Li W, Zhang Y, Qin S, et al. Discovering Biomarkers in Peritoneal Metastasis of Gastric Cancer by Metabolomics. Onco Targets Ther. 2020;13:7199\u2013211.","journal-title":"Onco Targets Ther"},{"issue":"7","key":"1807_CR53","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.4049\/jimmunol.148.7.2207","volume":"148","author":"VA Fadok","year":"1992","unstructured":"Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol. 1992;148(7):2207\u201316.","journal-title":"J Immunol"},{"key":"1807_CR54","doi-asserted-by":"publisher","first-page":"14395","DOI":"10.18632\/oncotarget.14795","volume":"8","author":"J Lea","year":"2017","unstructured":"Lea J, Sharma R, Yang F, Zhu H, Ward ES. Detection of phosphatidylserine-positive exosomes as a diagnostic marker for ovarian malignancies: a proof of concept study. Oncotarget. 2017;8:14395\u2013407.","journal-title":"Oncotarget"},{"key":"1807_CR55","doi-asserted-by":"publisher","unstructured":"Birge RB, Boeltz S, Kumar S, Carlson J, Wanderley J, Calianese D, et al. Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer. Cell Death Differ Nat Publishing Group. 2016;23:962\u201378. https:\/\/doi.org\/10.1038\/cdd.2016.11.","DOI":"10.1038\/cdd.2016.11"},{"key":"1807_CR56","doi-asserted-by":"publisher","unstructured":"Hua Y, Zhang G, Liu Y, Tian X. Regulation of sphingolipid metabolism in the immune microenvironment of gastric cancer: current insights and future directions. Front Oncol. 2025;15:1\u20139. https:\/\/doi.org\/10.3389\/fonc.2025.1604227.","DOI":"10.3389\/fonc.2025.1604227"},{"key":"1807_CR57","first-page":"1","volume":"21","author":"Y Takanashi","year":"2021","unstructured":"Takanashi Y, Funai K, Eto F, Mizuno K, Kawase A, Tao H, et al. Decreased sphingomyelin (t34:1) is a candidate predictor for lung squamous cell carcinoma recurrence after radical surgery: a case-control study. BMC Cancer BMC Cancer. 2021;21:1\u201314.","journal-title":"BMC Cancer BMC Cancer"},{"key":"1807_CR58","first-page":"1","volume":"20","author":"Y Takanashi","year":"2020","unstructured":"Takanashi Y, Funai K, Sato S, Kawase A, Tao H, Takahashi Y, et al. Sphingomyelin (d35:1) as a novel predictor for lung adenocarcinoma recurrence after a radical surgery: a case-control study. BMC Cancer BMC Cancer. 2020;20:1\u201311.","journal-title":"BMC Cancer BMC Cancer"},{"key":"1807_CR59","first-page":"1","volume":"20","author":"H Tallima","year":"2021","unstructured":"Tallima H, Azzazy HME, Ridi R, El. Cell surface sphingomyelin: key role in cancer initiation, progression, and immune evasion. Lipids Health Dis Lipids Health Disease. 2021;20:1\u201312.","journal-title":"Lipids Health Dis Lipids Health Disease"}],"container-title":["Gastric Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-026-01807-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10120-026-01807-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-026-01807-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T05:28:32Z","timestamp":1792646912000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10120-026-01807-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,22]]},"references-count":59,"alternative-id":["1807"],"URL":"https:\/\/doi.org\/10.1007\/s10120-026-01807-x","relation":{},"ISSN":["1436-3291","1436-3305"],"issn-type":[{"value":"1436-3291","type":"print"},{"value":"1436-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,22]]},"assertion":[{"value":"29 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Hamamatsu University School of Medicine, Hamamatsu, Japan (#25\u2013272) and (#17\u2013039).","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}